As your body adapts to GLP-1 therapy, making these changes is key to staying on track
"When one has a decreased appetite, they may think that they do not need any insulin, and if [insulin is] held or dosed sub-optimally, it could theoretically increase the risk of DKA," said Dr
Stimulating these central amygdalar neurons curtails hedonic feeding, whereas targeted deletion of the receptor in this cell population specifically diminishes the anorectic efficacy of GLP1RAs for reward-driven intake
Bristol: Journal of Endocrinology Ltd
Blood sugar improvements, if they are going to occur, will be measurable
In fact, they report that about 2540% of the weight lost on GLP-1 drugs is fat-free mass (muscle and other lean tissue), a much higher fraction than typically seen with diet-and-exercise weight loss